Search Result "Quizartinib"
Second-Generation Protein Kinase Inhibitor â A Focus on Quizartinib, A Promising Targeted Therapy for High-Risk FLT3+ Patients with Acute Myeloid Leukemia
Ebook: Frontiers in Clinical Drug Research - Anti-Cancer Agents
Volume: 5 Year: 2019
Author(s): Xavier Thomas,Etienne Paubelle
Doi: 10.2174/9789811405150119050003
FLT3 Inhibition in Acute Myeloid Leukaemia â Current Knowledge and Future Prospects
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 7 Year: 2020 Page: 513-531
Author(s): Francesca L. Hogan,Victoria Williams,Steven Knapper
FLT3 Inhibitors in the Management of Acute Myeloid Leukemia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 8 Year: 2017 Page: 1028-1032
Author(s): E. Zappone,M. Defina,L. Aprile,G. Bartalucci,A. Gozzetti,M. Bocchia
Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia
Journal: Current Cancer Therapy Reviews
Volume: 9 Issue: 3 Year: 2013 Page: 181-219
Author(s): Ugo Testa
Design and Synthesis of New Sulfonamides-Based Flt3 Inhibitors
Journal: Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2020 Page: 403-412
Author(s): Reem F. Abutayeh,Jehad Almaliti,Mutasem O. Taha
Protein Kinase Inhibitors as Therapeutic Drugs in AML: Advances and Challenges
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4303-4310
Author(s): Yuan Ling,Zikang Zhang,Hua Zhang,Zunnan Huang
Signal transduction in Acute Myeloid Leukemia â Implications for Novel Therapeutic Concepts.
Journal: Current Cancer Drug Targets
Volume: 15 Issue: 9 Year: 2015 Page: 803-821
Author(s): Heiko Konig,Cedric Dos Santos
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as AnticancerAgents for AML Treatment
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 29 Year: 2024 Page: 4657-4686
Author(s):
A Review on the Synthesis and Anticancer Potentials of ImidazothiazoleDerivatives
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 23 Issue: 17 Year: 2023 Page: 1733-1759
Author(s): M. Mumtaz Alam
Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 20 Issue: 6 Year: 2020 Page: 483-497
Author(s): Xu Hu,Yan Wang,Xiang Gao,Shengtao Xu,Linghe Zang,Yan Xiao,Zhanlin Li,Huiming Hua,Jinyi Xu,Dahong Li